Command Palette

Search for a command to run...

MEDPLUS
778.05(-0.78%)
1W: +3.53%

Medplus Health Services Peer Comparison

Snapshot Summary

Medplus Health Services Ltd. shows strong revenue growth and efficiency metrics compared to its peers, but its high PE ratio indicates it may be overvalued. Companies like Cipla and Dr. Reddy's Laboratories stand out for their profitability and reasonable valuation, while Divi's Laboratories faces challenges due to poor revenue growth.

  • Medplus has the highest revenue growth YoY among peers at 23.42%.
  • Cipla and Dr. Reddy's have the best profitability metrics, with ROE above 16%.
  • Divi's Laboratories is facing declining revenue growth and EPS, indicating potential weaknesses.
  • Cipla and Dr. Reddy's are attractive value picks due to low PE ratios and strong earnings performance.
  • Cipla Ltd.: Strong profitability metrics with a low PE ratio (23.73), indicating good value.
  • Dr. Reddy's Laboratories Ltd.: High ROE and low PE (15.50), making it financially attractive.
  • Mankind Pharma Ltd.: Good growth trajectory with strong ROE and low debt levels.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
MEDPLUS₹832.95₹9,969.91Cr247.2818.22%-
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.